Boc-Phe-(Alloc)Lys-PAB-PNP

Catalog No. :
ACOONZ221
CAS No. :
1160844-44-9
Molecular Formula :
C38H45N5O11
Molecular Weight :
747.80

IUPAC Name:allyl ((S)-6-amino-5-((S)-2-((tert-butoxycarbonyl)amino)-N-(4-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenyl)-3-phenylpropanamido)-6-oxohexyl)carbamate

Boc-Phe-(Alloc)Lys-PAB-PNP structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$1409.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBoc-Phe-(Alloc)Lys-PAB-PNP
IUPAC Nameallyl ((S)-6-amino-5-((S)-2-((tert-butoxycarbonyl)amino)-N-(4-((((4-nitrophenoxy)carbonyl)oxy)methyl)phenyl)-3-phenylpropanamido)-6-oxohexyl)carbamate
MDL No.MFCD22200441
Molecular FormulaC38H45N5O11
Molecular Weight747.80
SMILESC=CCOC(=O)NCCCC[C@@H](C(N)=O)N(C(=O)[C@H](CC1=CC=CC=C1)NC(=O)OC(C)(C)C)C1=CC=C(COC(=O)OC2=CC=C([N+](=O)[O-])C=C2)C=C1
InChI KeyZFWAEVQMHYNGJL-ACHIHNKUSA-N
SynonymBoc-Phe-(Alloc)Lys-PAB-PNP;L-Lysinamide, N-[(1,1-dimethylethoxy)carbonyl]-L-phenylalanyl-N-[4-[[[(4-nitrophenoxy)carbonyl]oxy]methyl]phenyl]-N6-[(2-propen-1-yloxy)carbonyl]-
CAS No.1160844-44-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACOONZ221 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOONZ221 route product structure diagram
    ACOONZ2211160844-44-9
Inquiry

2. ACOONZ221 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOONZ221 route product structure diagram
    ACOONZ2211160844-44-9
Inquiry

Comments (0)